Literature DB >> 11327253

How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.

K A Boki1, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos, H M Moutsopoulos.   

Abstract

OBJECTIVE: We evaluated whether sensorineural loss and vestibular abnormalities are common in patients with primary Sjögren's syndrome (pSS) and whether such abnormalities are clinically significant.
METHODS: In an individually matched case-control design, 48 patients with pSS underwent complete audiovestibular evaluation along with 48 age and sex matched individuals without otologic problems. Differences of > 20 dB between patient and control ears at any frequency tested were considered to be significant.
RESULTS: Significant differences in hearing loss were seen at 4,000 Hz (6 vs 0 ears; p = 0.03) and at 8,000 Hz (9 vs 0 ears; p = 0.003). Small differences in hearing acuity were also observed in the lower frequencies, but the absolute mean difference was < 3 dB. A decrease of at least 60 dB in hearing acuity at any frequency up to 4,000 Hz was seen only in 3 elderly pSS patients. Abnormal brainstem auditory evoked responses were recorded in 7 patients and 5 controls, but no patient had retrocochlear lesions identified on magnetic resonance imaging. Four patients in each group had abnormalities on electronystagmography.
CONCLUSION: pSS is associated with sensorineural hearing loss affecting preferentially the high frequencies, but clinically significant defects are not common. There is no evidence of retrocochlear disease or increased vestibular involvement in pSS.

Entities:  

Mesh:

Year:  2001        PMID: 11327253

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

2.  Primary Sjögren's syndrome manifesting as multiple cranial neuropathies: MRI findings.

Authors:  V V Ashraf; Ramesh Bhasi; R Praveen Kumar; A S Girija
Journal:  Ann Indian Acad Neurol       Date:  2009-04       Impact factor: 1.383

3.  Extended high-frequency audiometry as early detection of hearing loss in primary Sjögren syndrome.

Authors:  José Luis Treviño González; Janett Riega Torres; Yolisa Hinojosa Ríos; Mario Jesús Villegas González; Marco A Mendez Saenz; German A Soto-Galindo
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

Review 4.  Primary Sjögren's syndrome: new clinical and therapeutic concepts.

Authors:  M Ramos-Casals; A G Tzioufas; J Font
Journal:  Ann Rheum Dis       Date:  2004-10-21       Impact factor: 19.103

5.  Audiological Profile in Primary Sjögren's Syndrome in a Tertiary Care Setting and its Clinical Implications.

Authors:  C V Thanooja; Ann Mary Augustine; Anjali Lepcha; Pulukool Sandhya; Amit Kumar Tyagi; Debashish Danda; Achamma Balraj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-17

6.  Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity.

Authors:  Anna Lonyai; Shohta Kodama; Douglas Burger; Denise L Faustman
Journal:  Immunol Cell Biol       Date:  2008-02-26       Impact factor: 5.126

Review 7.  Audiovestibular Symptoms in Systemic Autoimmune Diseases.

Authors:  Massimo Ralli; Vittorio D'Aguanno; Arianna Di Stadio; Armando De Virgilio; Adelchi Croce; Lucia Longo; Antonio Greco; Marco de Vincentiis
Journal:  J Immunol Res       Date:  2018-08-19       Impact factor: 4.818

8.  Adipose-derived stem cells postpone the progression of Sjögren's syndrome by upregulating the Hippo signaling pathway.

Authors:  Zizhan Li; Xinli Fan; Xiuying Xu; Qin Zhou; Guimiao Xing; Gangli Liu
Journal:  Exp Ther Med       Date:  2022-07-22       Impact factor: 2.751

9.  The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.

Authors:  Tone B Enger; Arman Samad-Zadeh; Meghan P Bouchie; Kathrine Skarstein; Hilde K Galtung; Toshiyuki Mera; Janice Walker; A Sue Menko; Xaralabos Varelas; Denise L Faustman; Janicke L Jensen; Maria A Kukuruzinska
Journal:  Lab Invest       Date:  2013-09-30       Impact factor: 5.662

10.  Brainstem auditory evoked potentials in patients with primary Sjögren's syndrome without central nervous system involvement.

Authors:  Marta Waliszewska-Prosół; Agata Sebastian; Piotr Wiland; Sławomir Budrewicz; Edyta Dziadkowiak; Maria Ejma
Journal:  Clin Rheumatol       Date:  2020-08-18       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.